Effective on trade date December 21, 2023, and pending all relevant CFTC regulatory review periods, this Market Regulation Advisory Notice will supersede CME Group Market Regulation Advisory Notice RA2304-5 from July 13, 2023. It is being issued to revise the contact list, remove the references to the exception on the eligibility of CME full-sized Standard & Poor’s 500 Stock Price Index Options as part of Exchange of Option for Option (“EOO”) transaction upon terminated trading of CME full-sized Standard & Poor’s 500 Stock Price Index contracts in Q&A 4, codify existing guidance for pricing on for TAS, TAM or TMAC transactions in Q&A 11, and clarify language on delivery quantity confirmation in Q&A 28.
Highlight HERE and link to the advisory PDF.